Background {#Sec1}
==========

Hereditary sensory and autonomic neuropathy (HSAN) comprises a group of genetic disorders involving sensory and autonomic dysfunctions \[[@CR1]\]. HSAN was classified into five main types \[[@CR2]\]. Later, it was modified into subtypes \[[@CR3]--[@CR5]\] according to gene mutations, mode of inheritance, and clinical characteristics. HSAN types VI and VII were mentioned in the classification of Haga *et al*. \[[@CR5]\]: Online Mendelian Inheritance in Man (OMIM) 614653 and 615548 respectively. HSAN type VIII (OMIM 616488) was recently characterized by Chen *et al*. \[[@CR6]\] as a rare autosomal recessive disorder. Our patient's family was included in their study. General characteristics, mode of inheritance, onset, and genes involved in each type of HSAN are presented in Table [1](#Tab1){ref-type="table"}.Table 1Classification of recent types and subtypes of hereditary sensory (and autonomic) neuropathyTypes of HSANOMIMInheri.OnsetClinical characteristicsSomatosensory modalitiesSweatingGenes/ locusHSAN-IA \[[@CR2], [@CR25], [@CR28], [@CR33], [@CR34]\]162400ADMostly adolescence to adulthoodHearing loss, loss of distal reflexes/distal muscle weakness, (no autonomic dysfunction)Loss of pain and temperature sensation, lancinating painNormal*SPTLC1/9q22.31*HSAN-IB \[[@CR2], [@CR25], [@CR28], [@CR33]--[@CR35]\]608088ADAdulthoodChronic cough, gastropharyngeal reflux, hearing loss, alacrima, impotenceSensory loss, lancinating painNormal to mild distal hypohidrosis*SPTLC1/3p24-p22*HSAN-IC \[[@CR2], [@CR25], [@CR28], [@CR33], [@CR34], [@CR36]\]613640ADMostly adulthoodUlcerative mutilations, variable distal motor involvement, distal muscle weakness, osteomyelitisLoss of pain, lancinating pain, loss of temperature sensation in parts of the body, sensory loss in the upper and lower limbsNormal*SPTLC2/14q24.3*HSN-ID \[[@CR2], [@CR25], [@CR28], [@CR33], [@CR34], [@CR37]\]613708ADAdulthoodUlcerative mutilations, trophic skin and nail changes, distal amyotrophy in the lower limbsDistal sensory loss of the lower limbsNormal*ATL1/14q22.1*HSN-IE \[[@CR2], [@CR25], [@CR28], [@CR33], [@CR34], [@CR38]\]614116ADAdulthoodUlcerative mutilations, hearing loss, dementiaLoss of all somatosensory modalities, lancinating painNormal*DNMT1/19p13.2*HSN-IF \[[@CR2], [@CR25], [@CR28], [@CR33], [@CR34], [@CR39]\]615632ADAdulthoodNo autonomic involvement, diminished tendon reflexes, painless ulceration of the feetDistal sensory loss of the lower limbsNormal*ATL3/11q13.1*HSAN-IIA \[[@CR2], [@CR25], [@CR28], [@CR33], [@CR34], [@CR40]\]201300ARChildhoodSelf-mutilation behavior resulting in extensive orofacial injuries, weakness, acropathyLoss of pain, temperature and touch sensation, no autonomic dysfunctionNormal*WNK1/12p13.33*HSAN-IIB \[[@CR2], [@CR25], [@CR28], [@CR33], [@CR34], [@CR41]\]613114ARChildhoodUlcerative mutilation of hands, feet, and orofacial structures, osteomyelitis, urge incontinenceImpaired nociceptionHyperhidrosis*FAM134B/5p15.1*HSN-IIC \[[@CR2], [@CR25], [@CR28], [@CR33], [@CR34], [@CR42]\]614213ARChildhood to adolescenceUlcerative mutilation and orofacial injuries, absent deep tendon reflexes, minor distal weakness, distal numbness of the hands and feetImpaired position vibration sensesN/A*KIF1A/2937.3*HSAN-IID \[[@CR2], [@CR4], [@CR25], [@CR28], [@CR33], [@CR34], [@CR43]\]243000ARCongenital or adolescenceAutonomic nervous dysfunction, hearing loss, hyposmia, bone dysplasia, orofacial self-mutilation injuriesLoss of pain and temperature sensation, hypogeusiaHypohidrosis*SCN9A/2q24.3*HSAN-III \[2, 26, 29, 33, 34, 44, 58 63--66\]223900ARCongenitalProfound autonomic dysfunction, vasomotor instability, absence of deep tendon reflexes, alacrima, impaired blood pressure regulation, failure to thrive, orofacial self-mutilation, absent fungiform papillae on the tongue, increased salivation, low caries indexLoss of pain and temperature sensationHyperhidrosis*IKBKAP/9q31.3*HSAN-IV \[[@CR2], [@CR8], [@CR9], [@CR11], [@CR13], [@CR14], [@CR26], [@CR28], [@CR29], [@CR34], [@CR35], [@CR44]--[@CR51]\]256800ARCongenitalSelf-mutilation with orofacial injuries, deep tendon reflexes usually intact, recurrent fever, corneal lesions, mental retardation, recurrent infections, skin hyperkeratosis and fissuring, generalized tonic-clonic seizuresLoss of pain and temperature sensationHypohidrosis to anhidrosis*NTRK1/1q23.1*HSAN-V \[[@CR2], [@CR26], [@CR29], [@CR34], [@CR35], [@CR52]\]608654ARCongenitalSimilar to HSAN IVLoss of pain and reduced thermal sensation, loss of deep pain perceptionNormal to hypohidrosis*NGFB/1p13.2*HSAN-VI \[[@CR33], [@CR53]\]614653ARCongenitalLack of psychomotor development, autonomic abnormalities, absence of deep tendon reflexes, feeding and respiratory difficulties, neonatal hypotonia, alacrima, blotchingLoss of pain and temperature sensationN/A*DST/6p12.1*HSAN-VII \[[@CR33], [@CR54], [@CR55]\]615548ADCongenitalSelf-mutilation, painless fractures, delayed motor development, gastrointestinal dysfunctionLoss of pain sensationHyperhidrosis*SCN11A/3p22.2*HSAN-VIII \[[@CR6], [@CR30]\]616488AROnset in infancySelf-mutilation behavior with orofacial injuries, painless fractures, skin and bone infections, corneal injuries, no mental retardationReduced pain and temperature sensationHypohidrosis*PRDM12/9q34.12*HSN with spastic paraplegia \[[@CR33], [@CR34]\]256840AREarly childhoodMutilation acropathy, septic paraplegiaLoss of all somatosensory modalitiesNormal*CCT5/5p15.2AD* autosomal dominant, *AR* autosomal recessive, *ATL1* atlastin GTPase 1, *ATL3* atlastin GTPase 3, *CCT5* chaperonin TCP1 subunit 5, *DNMT1* DNA (cytosine-5-)-methyltransferase 1, *DST* dystonin, *FAM134B* family with sequence similarity 134 member B, *HSAN* hereditary sensory and autonomic neuropathy, *HSN* hereditary sensory neuropathy, *IKBKAP* inhibitor of kappa light polypeptide gene enhancer in B-cells kinase complex-associated protein, *Inheri.* mode of inheritance, *KIF1A* kinesin family member 1A, *N/A* not available, *NGFB* nerve growth factor (beta polypeptide), *NTRK1* neurotrophic tyrosine kinase-1 receptor, *OMIM* Online Mendelian Inheritance in Man, *PRDM12* PR domain-containing protein 12, *SCN9A* sodium channel, voltage gated type IX alpha subunit, *SCN11A* sodium channel, voltage gated, type XI alpha subunit, *SPTLC1*, serine palmitoyltransferase long chain base subunit 1, *SPTLC2*, serine palmitoyltransferase long chain base subunit 2, *WNK1* WNK lysine deficient protein kinase 1

HSAN-VIII is characterized by five main features: insensitivity to pain and thermal stimuli, self-mutilation behavior, altered sweat and tear formation, absence of corneal reflexes, and presence of repeated infections of the skin and bone \[[@CR6]\]. The syndrome was confirmed in 21 patients \[[@CR6]\] and 10 different homozygous mutations in the PR domain-containing protein 12 gene (*PRDM12*) were identified \[[@CR6]\]. Mutations in the *PRDM12* gene in humans cause developmental defects in the sensory neurons, leading to loss of pain perception. Great loss of the small myelinated Aδ fibers occurred in patients with HSAN-VIII. Skin biopsies revealed that the peripheral terminals of unmyelinated C fibers were altered \[[@CR6]\].

Patients carrying *PRDM12* mutations lack the sensation of acute pain and temperature. Thus, these patients have numerous injuries, which may lead to recurrent infections of skin and bones, and bone deformities later in life. In addition, they lack corneal reflexes, which leads to progressive corneal scarring. However, other senses like light touch, vibration, and proprioception are normal. The only autonomic dysfunction observed was the reduction in sweating and tears formation. Intellectual abilities in patients with HSAN-VIII are normal \[[@CR6]\].

Insensitivity to pain leads to severe oral mutilations, such as tooth luxation, severe dental attrition, premature tooth loss, bite wounds, and ulcerations \[[@CR7]--[@CR9]\]. The tongue, followed by the lips, and the oral mucosa, are the most common sites of self-inflicted injuries \[[@CR10], [@CR11]\]. The diagnosis of HSAN is challenging due to its rarity, similarity in clinical presentation to other auto-aggression or self-mutilation diseases, and lack of simple diagnostic tests \[[@CR12]\]. It is mainly confirmed by the clinical presentation, genetic analysis, pharmacological tests, and neuropathological examinations \[[@CR13]\]. Management of patients affected by HSAN-VIII is complicated due to the patients' lack of awareness and perception of pain.

We aimed to present the manifestations and dental management of a patient with HSAN-VIII harboring the homozygous mutation *c.516G\>C* (*p. Glu172Asp*) in the *PRDM12* gene \[[@CR6]\], who has been followed up in our clinic for 16 years. A review on PubMed library (January 1985 to December 2016) on patients with HSAN with oral manifestations was performed (Table [2](#Tab2){ref-type="table"}).Table 2Literature review concerning oral manifestations associated with hereditary sensory (and autonomic) neuropathyYear of pub.AuthorsTypeGeneCountry/ ethnic groupTsNAgeGGeneral characteristicsOral manifestations2016Eregowda *et al*. \[[@CR56]\]IV*NTRK1*India/ IndianCR111 yFThermal insensitivity, anhidrosis, low intelligence, deformed interphalangeal joints of fingers, corneal scarring, skin infections, osteomyelitisOral self-mutilation, dental traumata2015Ravichandra *et al*. \[[@CR13]\]IV*NTRK1*India/\
N/ACR17 yFInsensitivity to pain and temperature, anhidrosis, self-mutilation, preservation of other sensory modalities, recurrent feverOrofacial self-mutilation, dental traumata2015Ashwin *et al*. \[[@CR11]\]IV*NTRK1*India/\
N/ACS84--17 y6 M\
2 FInsensitivity to pain, self-mutilation, recurrent fever, recurrent infection in the lower limbsOral self-mutilation2015Chen *et al*. \[[@CR6]\]VIII*PRDM12*Inter/\
InterGA213--40 y13 M\
8 FInsensitivity to pain and temperature, hypohidrosis, self-mutilation behavior, skin and bone infections, painless fractures, corneal injuries, no mental retardationOrofacial self-mutilation2014Özkaya *et al*. \[[@CR57]\]IV*NTRK1*Turkey/\
N/ACR110 yMRecurrent fever, anhidrosis, ulcers on the skin, osteomyelitis, hyperkeratotic lesions on elbows and kneesOrofacial self-mutilation2014Guven *et al*. \[[@CR44]\]IV*NTRK1*Turkey/\
Turkish descentCS21 y, 17 yMInsensitivity to pain and temperature, self-mutilation behavior, non-healing skin, ulcerations on the dorsum of the hands, anhidrosis, hypo- and hyper-pigmented skinOrofacial self-mutilation2013Gao *et al*. \[[@CR8]\]IV*NTRK1*China/\
N/ACR18 mMRecurrent fevers, anhidrosis,\
dry warm skin, congenital corneitisOral self-mutilation, dental caries, malocclusion, cleft palate2013Fruchtman *et al*. \[[@CR58]\]IVN/AIsrael/\
N/ACS301 m--15 y16 M\
14 FInfections, fever, orthopedic lesionsOrofacial self-mutilation2010Hutton and McKaig \[[@CR45]\]VN/AUK/\
N/ACR16 yFN/AOrofacial self-mutilation2010Zilberman *et al*. \[[@CR46]\]IIIN/AIsrael/\
N/AHA17N/AN/AN/AThicker enamel formation2009Neves *et al*. \[[@CR9]\]IV*NTRK1*Brazil/\
N/ACR12 yFUnexplained fever episodes, anhidrosis, self-mutilation behavior, mental retardationOral self-mutilation2009Paduano *et al*. \[[@CR59]\]IVN/AItaly/\
Italian descentCR18.11 yMSelf-mutilation, recurrent fever, osteomyelitisOral ulcers, limited mouth opening2008Romero *et al*. \[[@CR60]\]IVN/ASpain/\
N/ACR122 mFSelf-mutilation, recurrent feverOrofacial self-mutilation2008Singla *et al*. \[[@CR47]\]VN/AIndia/\
Indian descentCR110 yMInsensitivity to pain, normal response to thermal stimuli, bilateral corneal opacities, hypoplasia of the nipplesPresence of severe maxillary ridge resorption, congenitally missing permanent teeth2006Butler *et al*. \[[@CR25]\]IV*NTRK1*Ireland/\
N/ACR19 mMSelf-mutilation injuries on wrist and feet, insensitivity to pain, normal reaction to thermal stimuliOrofacial self-mutilation2006Schalka *et al*. \[[@CR27]\]IVN/ABrazil/\
CaucasianCR116 mFLack of painful stimuli, episodes of unexplained fever, hypohidrosisOrofacial self-mutilation2006Siqueira *et al*. \[[@CR48]\]VN/ABrazil/\
N/ACS222 y, 16 y1 M\
1 FInsensitivity to pain, self-mutilation behaviorOrofacial self-mutilation2003Bonkowsky *et al*. \[[@CR12]\]IV*NTRK1*USA/\
Northern EuropeanCR14 mMHyperkeratosis on palms, skin fissuringOrofacial self-mutilation2002Mass *et al*. \[[@CR52]\]IIIN/AIsrael/ Ashkenazi-Jewish descentCS28N/AN/AN/ALow levels of mutans streptococci and lactobacilli in saliva, high salivary flow2002Wolf *et al*. \[[@CR61]\]IIIN/AIsrael/ Ashkenazi-Jewish descentCS466--16 y31 M\
15 FImpaired pain perception, skeletal deformities, small stature, failure to thrive, recurrent pneumonia, orthostatic hypotensionProgressive degeneration of tongue fungiform papillae and taste buds, impaired taste, excessive drooling, impaired swallowing2000Theodorou *et al*. \[[@CR62]\]IVN/AGreece/\
N/ACR14 yMInsensitivity to pain, self-mutilation, bone fractures, anhidrosis, mental retardationOrofacial self-mutilation2000Erdem *et al*. \[[@CR49]\]IVN/ATurkey/\
N/ACR110 yMAcute tibia osteomyelitis, broken finger tipsMalformed oral configuration, orofacial self-mutilation1999Kim *et al*. \[[@CR50]\]IVN/AKorea/\
N/ACR116 mMSelf-mutilation, fever, anhidrosis, generalized tonic-clonic seizuresOrofacial self-mutilation1998Amano *et al*. \[[@CR7]\]IVN/AJapan/\
AsianCS181--22 y12 M\
6 FSelf-mutilation behavior, insensitivity to pain, anhidrosis, infections, malnutritionOrofacial mutilation, premature loss of teeth, intraoral scars and ulcers, severe bruxism, dental traumata, halitosis1998Rodd *et al*. \[[@CR51]\]IIN/AUK/\
AsianCR14 yMSensory loss affecting all modalities of sensation predominantly involving the limbs, mutilation, anhidrosis, acropathy of finger tips and feetFull-thickness loss of the tongue tip, tissue loss from the lower lip, loss of pain sensation1998Mass *et al*. \[[@CR63]\]IIIN/AIsrael/ Ashkenazi-Jewish descentCS325.8--19.8 y17 M\
15 FDecreased pain sensation, impaired temperature and blood pressure regulation, alacrima, absent tendon reflexesOrofacial self-mutilation, dental traumata, low caries index, hypersalivation, absence of the fungiform papillae on the tongue1996Mass *et al*. \[[@CR64]\]IIIN/AIsrael/ Ashkenazi-Jewish descentCS205--39 y14 M\
6 FDecreased pain sensation, impaired temperature and blood pressure regulation, alacrima, absent tendon reflexesOrofacial self-mutilation1994Mass and Gadoth \[[@CR65]\]IIIN/AIsrael/ Ashkenazi-Jewish descentCS38N/A23 M\
15 FDecreased pain sensation, impaired temperature and blood pressure regulation, alacrima, absent tendon reflexesDental traumata1992Mass *et al.* \[[@CR66]\]IIIN/AIsrael/ Ashkenazi-Jewish descentCS66N/AN/ADecreased pain sensation, impaired temperature, impaired blood pressure regulation, absent tendon reflexes, alacrimaOrofacial self-mutilation, dental traumata, low caries index, hypersalivation, absence of the fungiform papillae on the tongue1989Kouvelas and Terzoglou \[[@CR28]\]IVN/AGreece/\
N/ACR15.5 yMInsensitivity to pain, self-mutilation, fever, anhidrosisOrofacial mutilation1987Brahim *et al*. \[[@CR67]\]IVN/AUSA/\
N/ACR211 y,\
7 yMSelf-mutilation, fever, anhidrosis, osteomyelitisOrofacial mutilation1986Thompson *et al*. \[[@CR68]\]IIIN/AUSA/\
CaucasianCR131 yMInsensitivity to pain, blotching of skin, diminished lacrimationOrofacial mutilation (including auto-extraction of teeth), diminished taste sensation2016Zhang *et al*. \[[@CR30]\]VIII*PRDM12*N/ACS523--57 y4 M\
1 FInsensitivity to pain, normal neurological examinations and intellect, corneal abrasions, lack of tear production, recurrent infections, unexplained self-mutilationUnexplained orofacial mutilationReview articles2015Haga *et al*. \[[@CR5]\]IV, V*NTRK1, NGFB*Japan/\
N/ARAN/AN/AN/ARepeated fractures, joint dislocations, arthritis, osteomyelitis, avascular necrosis, Charcot arthropathyOral self-mutilation (including auto-extraction of teeth)2014Kumar *et al*. \[[@CR69]\]IV*NTRK1*India/\
N/ARAN/AN/AN/AN/AOrofacial self-mutilation, premature loss of teeth, osteomyelitis, fractures of the jaws2013Limeres *et al*. \[[@CR26]\]IVN/ASpain/\
N/ARAN/AN/AN/AN/AOral self-mutilation (including auto-extraction of teeth)2012Mass \[[@CR70]\]III*IKBKAP*N/A /\
N/ARAN/AN/AN/AInsensitivity to pain and temperature, vasomotor instability, respiratory distress, orthostatic hypotension, insensitivity to hypoxia, decreased deep tendon reflexes, alacrimaAbsence of fungiform papilla, dental traumata, orofacial self-mutilation, proportionally small jaws, crowding of teeth, low caries rate, hypersalivation, impaired taste sensation2003Nagasako *et al*. \[[@CR71]\]HSAN IVN/AUSA/\
N/ARAN/AN/AN/AInsensitivity to pain, self-mutilation, painless fractures, fever, hypohidrosisOrofacial self-mutilation*CR* case report, *CS* case series, *F* female, *G* gender, *GA* genetics article, *HA* histological article, *IKBKAP* inhibitor of kappa light polypeptide gene enhancer in B-cells kinase complex-associated protein, *Inter* international, *m* month(s), *M* male, *N* number of patients, *N/A* not available, *NGFB* nerve growth factor (beta polypeptide), *NTRK1* neurotrophic tyrosine kinase-1 receptor, *PRDM12* PR domain-containing protein 12, *Pub*. publication, *RA* review article, *Ts* type of study, *y* year(s), UK United Kingdom, USA United States of America

Case presentation {#Sec2}
=================

An 8-month-old white boy of Turkish origin initially presented to the Department of Pedodontics, at Charité -- Universitätsmedizin Berlin Hospital, due to an unexplained early loss of his primary lower central incisors. He was the first child of healthy consanguineous parents (second-degree relatives); their younger daughter was healthy. Our patient had multiple injuries on his face and body and in his oral cavity due to self-mutilation (Fig. [1](#Fig1){ref-type="fig"}). Further medical history revealed that he was born with a bilateral foot deformity (Fig. [2](#Fig2){ref-type="fig"}), which resulted in the mandatory use of an orthopedic appliance, enabling him to walk normally (Fig. [3](#Fig3){ref-type="fig"}). At the age of 6 years and 2 months, he had a fracture in the metatarsal bone, leading to bone necrosis. This resulted in the placement of bone plates and the use of a wheelchair for long walking distances. He had several accidents, such as severe burns from boiling water without feeling any pain.Fig. 1Representation of self-mutilation. **a**+**b** Extraoral self-mutilation. **c**+**d** Intraoral self-mutilation Fig. 2Bilateral bone deformity of the feet. **a** Clinical presentation of the deformed feet. **b** Radiographic presentation of the deformed feet Fig. 3Orthopedic appliance used to support the patient's feet during walking. **a**+**c** Orthopedic appliance. **b**+**d** Patient wearing his orthodontic appliance

Prior to the first visit to the Department of Pedodontics at the age of 8 months, he had lost both mandibular primary central incisors for unknown reasons only 3 months after they erupted. His mandibular left lateral incisor was loose (mobility, grade 2). In addition, his mandibular left primary second molar (75) showed signs of enamel hypoplasia. He experienced no pain or discomfort during the dental procedures. A year later, he presented at our department due to the further loss of ten of his primary teeth (Fig. [4](#Fig4){ref-type="fig"}). The early loss of so many teeth raised suspicion of a systemic disorder. He was referred to the Department of Human Genetics at Charité -- Universitätsmedizin Berlin. The following differential diagnoses of auto-aggression syndromes were suspected: congenital insensitivity to pain and anhidrosis (CIPA), Smith--Magenis syndrome, Lesch--Nyhan syndrome, or pantothenate kinase-associated neurodegeneration (PKAN). In addition, the following systemic diseases, which might cause premature loss of teeth, were suspected: Langerhans cell histiocytosis, hypophosphatasia, and Papillon--Lefèvre syndrome. The diagnosis of CIPA syndrome was thought to be closest to his condition. All other suspected auto-aggression syndromes and systemic diseases were excluded based on blood tests, genetic diagnosis, and further clinical examination. However, after deeper investigations, the diagnosis HSAN-VIII was considered the definitive diagnosis of our patient.Fig. 4Auto-extracted teeth of the patient

Partial dentures for maxilla and mandible were constructed to prevent speech impairment and to enhance his lower facial height (Fig. [5](#Fig5){ref-type="fig"}). Due to his high caries activity, an intensive prophylaxis program with continuous follow-up was implemented to avoid further dental deterioration and improve his oral health status. Over the years, with the help of an interdisciplinary medical team and his parents, he has shown great cooperation and completely ceased any sort of self-mutilation behavior.Fig. 5Prosthodontic treatment of the patient. (**a**+**b**) Intraoral pictures of patient without and with prostheses, respectively

Discussion {#Sec3}
==========

The pediatric dentist was the first to refer our patient to the human genetics department with the suspicion of HSAN syndrome, based on the premature loss of primary teeth and self-mutilation behavior. The initial diagnosis of our patient of CIPA or HSAN-IV was not confirmed by molecular analysis, since it did not detect a mutation in the neurotrophic tyrosine kinase-1 receptor gene (*NTRK1*), which is the receptor for nerve growth factor (NGF) related to CIPA syndrome \[[@CR12]\]. Our patient harbored a homozygous mutation in the recently discovered gene *PRDM12* \[[@CR6]\]. Therefore, HSAN-VIII was his final diagnosis. Deoxyribonucleic acid (DNA) sequencing of the parents confirmed the segregation of the mutation in the family. The mode of inheritance was autosomal recessive \[[@CR6]\]. Self-mutilation behavior is one of the most outstanding characteristics of HSAN syndrome. However, it is also common in other auto-aggression diseases, which makes the diagnosis challenging. Smith--Magenis syndrome was a differential diagnosis concerning the self-inflicted injuries \[[@CR14]\], but a causative *17p.11.2* microdeletion was excluded by fluorescence *in situ* hybridization. As for Lesch--Nyhan syndrome, patients have dystonia and ballism \[[@CR15]\], which were not symptoms of our patient. Further analysis did not reveal defects in the hypoxanthine-guanine phosphoribosyltransferase (HPRT) enzyme, confirming the false diagnosis. PKAN is also characterized by dystonia and therefore was ruled out \[[@CR16]--[@CR19]\]. Blood tests excluded the systemic diseases of Langerhans cell histiocytosis and hypophosphatasia \[[@CR20]\]. Hypophosphatasia was also excluded because of our patient's normal total serum alkaline phosphatase activity \[[@CR21]--[@CR23]\]. Papillon--Lefèvre syndrome was not confirmed due to the absence of the diffuse palmoplantar hyperkeratosis and the progressive periodontitis \[[@CR24]\]. Oral manifestations of HSAN are important, since they are one of the first complaints presented by affected patients. They can be detected early in life, starting with the eruption of the primary dentition \[[@CR25]\]. Because of the variability and rarity of the clinical presentation of HSAN, no standard dental management protocols have been established. Patients with HSAN should be treated individually \[[@CR26]\]. The dental treatment planning can be affected by several factors, such as age, mental development, and patient's and parents' compliance \[[@CR27]\]. In the 1960s, the treatment approach for patients with HSAN was extraction of all primary teeth and construction of dentures in order to prevent self-mutilation. Nowadays, there are many dental treatment options for the prevention of self-mutilating behavior, varying from the elimination of sharp tooth surfaces by grinding or restoring them with resin composite, to the use of intraoral appliances such as mouthguards. Since the self-mutilation behavior of patients with HSAN-VIII starts in infancy, it may prove difficult to use intraoral appliances at that point. However, tooth extractions should be considered the last line of treatment. Early loss of teeth is one of the most frequent dental complications of HSAN. It is important to be able to deal with its consequences, such as speech impairment and increased incidence of malocclusions \[[@CR25], [@CR26], [@CR28]\]. Professional dental cleaning, behavioral management, and routine check-up appointments were the cornerstones of our treatment plan. Prevention of dental disease is required in patients with HSAN, since caries progression and pulpal involvement can occur without causing any pain or discomfort. The parents of patients with HSAN play a crucial role in the management of the condition, since their psychological support is necessary to help the child understand his or her condition and prevent further injuries \[[@CR27], [@CR28]\]. The most critical phase of managing patients with HSAN would be building an understanding of the emotional experience of pain. A psychological approach should be introduced as early as possible \[[@CR27]\]. Cognitive behavioral models for self-management and distress regulation have been proposed \[[@CR29]\].

The literature search revealed that HSAN-IV (CIPA) is the most discussed form of HSAN in dentistry. Self-mutilation and auto-aggression are the first and most common clinical characteristics in all mentioned HSAN types (Table [2](#Tab2){ref-type="table"}). The literature review results mainly consisted of case reports and case series, which is understandable due to the rarity of the syndrome. In contrast to our case report, a long follow-up period was not reported in the majority of publications. Our case report is, to the best of our knowledge, the first to discuss the oral manifestations and management of HSAN-VIII. Zhang *et al*. \[[@CR30]\] also reported on the clinical characteristics of five patients with HSAN-VIII and was in line with Chen *et al*. \[[@CR6]\]. The clinical characteristics described by Zhang *et al*. \[[@CR30]\] that were found in all patients were: insensitivity to pain, normal neurological examinations and intellect, corneal abrasions, lack of tear production, recurrent infections, and unexplained oral self-mutilation (especially tongue injuries). There is a need for further dental and medical management solutions for these patients, as well as for well-educated practitioners \[[@CR29]\]. There are many obstacles that have to be overcome since often there is a lack of resources for research and international collaboration and for accessible database and diagnostic and treatment tools. By expanding our knowledge on genetic and epigenetic factors that are critical for pain sensation, new fields are opened for therapeutic intervention in chronic and neuropathic pain conditions \[[@CR6], [@CR31], [@CR32]\].

Conclusions {#Sec4}
===========

HSAN-VIII is a rare, complex, recently identified condition mainly characterized by insensitivity to pain and thermal stimuli. The affected persons are vulnerable to various complications and in severe cases, self-mutilation can lead to death. Early identification of the disease is important to prevent all these consequences. The literature contains mainly case reports and case series of patients with HSAN, therefore, there are many knowledge gaps concerning preventive and therapeutic approaches. Treatment efficacy depends on educating the family and supporting the child psychologically. Moreover, an interdisciplinary treatment approach, in which there is medical and dental interdisciplinary cooperation, is required for such patients. A homozygous mutation of the *PRDM12* gene, which is responsible for the HSAN-VIII condition, was identified in our patient. Mutations in this gene cause developmental defects in sensory neurons before their transition to nociceptors.
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